Democrats are criticizing the Trump administration’s approach to Medicaid fraud, calling it a partisan tactic targeting blue states. A recent House hearing highlighted tensions over the Centers for Medicare & Medicaid Services’ (CMS) decision to withhold funding from California and Minnesota, citing fraud concerns. Republican lawmakers defended the effort as necessary to protect taxpayer money, while Democrats accused the administration of using fraud as a pretext to punish states that oppose Trump.
The CMS has deferred $1.3 billion in Medicaid payments to California and $350 million to Minnesota, claiming widespread fraud. California’s Medicaid director, Tyler Sadwith, said the state addressed CMS concerns before the deferral and provided data explaining growth in home-based services, which are cheaper than institutional care. “CMS decided to defer the payments, and they have not provided any instances of fraud, waste, or abuse as part of their review,” Sadwith said.
Related: BD’s Muhsin discusses AI for connected care
Minnesota’s Medicaid director, John Connolly, described the funding cuts as a “structural budget deficit” that threatens services for vulnerable residents. The state has conducted over 3,000 fraud investigations and recovered $50 million since 2020. However, Connolly noted shifting federal requirements have complicated efforts to restore funding. “We have no idea when the deferred payments might be reapproved,” he said.
New York faced similar scrutiny after CMS incorrectly claimed the state provided personal care services to 5 million people—later corrected to 450,000.
CMS officials denied targeting blue states, citing investigations in red states like Florida. However, Democrats argued the agency’s focus on blue states is partisan. “CMS is going out of its way to blindside blue states while pampering red ones,” Rep. Diana DeGette said, calling the Florida letter a “fig leaf” to mask bias.
Related: Two NJ Health Systems Explore Merger
Despite disputes, states have taken steps to combat fraud. California suspended 5,000 providers for fraud and recovered $1 billion in payments. New York has tightened oversight of high-risk benefits like hospice care. Medicaid directors emphasized collaboration with CMS but warned that cutting funding without clear guidelines harms beneficiaries. “These decisions affect Minnesotans with significant needs,” Connolly said. “We can protect program integrity while still operating these programs effectively.”
The Trump administration’s aggressive push to address Medicaid fraud has been accompanied by new federal mechanisms, including an executive order in March establishing a task force to coordinate efforts with the Department of Justice and CMS. This task force has worked to standardize fraud detection protocols and increase penalties for noncompliance, a move that has drawn criticism for its potential to disrupt state-level operations. The CMS has also expanded its use of prepayment reviews, requiring states to justify expenditures on high-risk services such as behavioral health and non-emergency medical transportation before funds are disbursed, a process that some state officials argue adds unnecessary administrative burdens.
Related: 5 Health Benefits of CBD
The debate over Medicaid funding has also extended to states that CMS has not targeted for deferrals, such as Ohio, where Republican lawmakers have faced scrutiny over alleged fraud in home health services. During the hearing, Energy and Commerce Chair Rep. Brett Guthrie defended the administration’s focus on fraud, emphasizing that investigations are based on evidence rather than political alignment. However, critics like DeGette have pointed to the lack of similar actions in red states as evidence of a partisan agenda. The CMS’s letter to Florida, which included a detailed audit of home health programs, has been presented as an example of the administration’s commitment to uniform enforcement, though some analysts question whether the Florida review was as thorough as those in blue states.
In response to the funding deferrals, states have intensified their own fraud prevention efforts. Minnesota, for instance, has expanded its oversight staff and implemented stricter prepayment reviews to block fraudulent claims before they are processed. California has introduced new safeguards in high-risk areas like hospice care, while New York has scaled back a program allowing members to hire private caregivers after identifying vulnerabilities to fraudulent billing. These measures, while effective in curbing fraud, have required significant resource allocation from state agencies already strained by the deferrals. Medicaid directors have repeatedly stressed the need for federal clarity on how states can regain lost funding, arguing that the current approach risks destabilizing healthcare access for millions of low-income Americans.
